3D心臟定位系統市場:現狀分析與預測(2024-2032年)

3D Cardiac Mapping System Market: Current Analysis and Forecast (2024-2032)

出版日期: 2024年07月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 131 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

3D心臟測繪系統市場預計將呈現約10%的成長率。這主要是由於心血管併發症的增加，由於越來越多的患者需要改進的診斷和治療方案，這也將擴大 3D 心臟繪圖系統市場。此外，這些公司還致力於研究和開髮用於心臟醫療應用的新繪圖技術，並為患者、客戶和醫護人員提供有效使用這些先進心臟繪圖系統的指導。的認識。例如，2022年4月，飛利浦在2022年歐洲心律協會年會上展示了其最新的KODEX-EPD心臟測繪和導航系統。

同樣在 2021 年 6 月，美國醫療創新公司 Cardiac Insights, Inc. 在 2021 年阿拉伯健康大會上推出了 Cardiac SOLO ECG 系統。 Cardea SOLO 將一次性、患者友善穿戴式心電圖感測器與 100% 醫生管理的診所自動化軟體結合。

依類型劃分，市場分為電解剖標測、籃式導管標測和即時位置管理（心臟通路）電生理系統。其中，電解剖測繪透過提供準確的即時心電活動視覺化，預計將在 3D 心臟測繪系統市場中佔據最大的市場佔有率。這項技術使心臟科醫生能夠創建心臟電通路的詳細解剖圖，這可以幫助診斷和治療心律不整和其他心臟疾病。電解剖測繪能夠提高手術效率、減少放射線暴露和改善病患治療效果，成為擴大 3D 心臟測繪系統全球採用和成長的關鍵驅動力。

根據應用，市場分為醫院和診所、門診手術中心等。其中，醫院和診所類別預計將佔據3D心臟測繪系統市場的最大市場佔有率。這是因為心血管疾病在醫療機構中變得越來越常見，而此類機構持續需要準確且高效的心臟測繪系統。透過實施這種 3D 心臟測繪系統，醫院和診所可以輕鬆提高診斷效果，提高病患滿意度和治療效率。這些醫院和診所不僅將提高3D心臟測繪系統的採用和使用率，而且還將透過不斷創新積極推動市場成長，並使3D心臟測繪系統成為心臟治療的主流，這就是我們大力投資新型和心臟治療的原因。

為了更了解 3D 心臟繪圖系統的市場介紹，市場分為北美（美國、加拿大、歐洲其他地區）、歐洲（德國、英國、法國、西班牙、義大利、歐洲其他地區）、亞洲太平洋地區（根據其他地區（中國、日本、印度、亞太其他地區）和其他地區的全球影響力進行分析。北美 3D 心臟測繪系統市場是指開發心臟電特性的全面且增強的幾何表示的技術解決方案的消費。推動這一市場的因素包括心律不整和其他疾病病例的增加、微創手術的成長趨勢以及測繪系統技術的快速成長。主要驅動因素包括測繪技術進步，以提高未來的準確性、更好的衛生系統、物聯網和醫療設備資訊提供和提供者關係、深化市場和提高人們的護理品質等。

市場上的主要公司包括雅培 (Abbott)、Acutus Medical, Inc.、BioSig Technologies, Inc.、Boston Scientific Corporation、Johnson & Johnson Services, Inc.、美敦力。

The market for 3D cardiac mapping systems is a relatively new and emerging segment of the medical devices market, specializing in the identification and treatment of life-threatening heart diseases. These systems give dynamic and detailed three-dimensional images of the electrical activity of the human heart therefore increasing the accuracy of cardiac procedures. Growth in the market is chiefly due to growth in the incidence of cardiovascular diseases, shifting trends in preference towards fewer invasive surgeries, and continuous innovation in technology used in cardiac mapping systems. Furthermore, a rise in healthcare costs, a rise in the geriatric population, as well as government support for the same makes the market more conducive.

The market for 3D cardiac mapping systems market is set to exhibit a growth rate of about 10%. This is mainly due to the rise of cardiovascular complications, which also increases the market for a 3D cardiac mapping system for patients, as more individuals require improved diagnosis and treatment options. Furthermore, the companies are engaged in R&D to develop new mapping techniques for cardiac medical applications and focus on expanding awareness of activities most relevant to patients, customers, and healthcare personnel for the effective use of these advanced cardiac mapping systems worldwide. For instance, in April 2022, Philips showcased its latest KODEX-EPD cardiac mapping and navigation system at the 2022 European Heart Rhythm Association annual meeting.

Also, in June 2021, Cardiac Insights, Inc., a United States-based healthcare innovator, launched its Cardea SOLO ECG System at Arab Health 2021. Cardea SOLO combines a single-use, patient-friendly wearable ECG sensor with 100% in-clinic automated software administered by physicians.

Based on type, the market is segmented into electroanatomical mapping, basket catheter mapping, and real-time positional management (cardiac pathways) EP system. Among these, electroanatomical mapping is expected to have the largest market share of the 3D cardiac mapping system market by offering precise, real-time visualization of cardiac electrical activity. This technology enables cardiologists to create detailed anatomical maps of the heart's electrical pathways, aiding in the diagnosis and treatment of arrhythmias and other cardiac conditions. Its ability to enhance procedural efficiency, reduce radiation exposure, and improve patient outcomes positions electroanatomical mapping as a critical driver in expanding the adoption and growth of 3D Cardiac Mapping Systems globally.

Based on the application, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others. Among these, the hospitals & clinics category is expected to have the largest market share of the 3D cardiac mapping systems market due to cardiovascular diseases have become more prevalent in healthcare facilities, and as such, these facilities are continually in need of accurate and efficient cardiac mapping systems. Due to the implementation of these 3D cardiac mapping systems, hospitals, and clinics can easily promote the effectiveness of their diagnosis and increase patient satisfaction and procedural efficiency. They invest heavily in new and advanced medical technology that not only enhances the adoption rates and utilization of 3D cardiac mapping systems but also actively drives the growth of the market through constant innovation and bringing 3D cardiac mapping systems to mainstream cardiac care.

For a better understanding of the market adoption of 3D cardiac mapping systems, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North American 3D cardiac mapping system market refers to the consumption of technology solutions through which comprehensive and enhanced geometrical representations of cardiac electrical characteristics are developed. The drivers of this market include growing cases of cardiac arrhythmias and other disorders, growing trends in minimally invasive surgeries, and the existing burgeoning of mapping systems technology. Some of the significant driving forces include advancements in technologies in mapping as a way of enhancing precision in the future, the good healthcare system, and the relationships between the Internet of Things and medical device informing and healthcare providers, deepening the market and improving the quality of care for the people.

Some of the major players operating in the market include Abbott; Acutus Medical, Inc.; APN Health, LLC; BioSig Technologies, Inc.; Biotronik; Boston Scientific Corporation; Catheter Precision Inc.; Johnson & Johnson Services, Inc.; Koninklijke Philips N.V.; and Medtronic.

1.MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Global 3D Cardiac Mapping System Market
2.2. Research Methodology of the Global 3D Cardiac Mapping System Market
2.3. Respondent Profile

3.EXECUTIVE SUMMARY

3.1. Industry Synopsis
3.2. Segmental Outlook
- 3.2.1. Market Growth Intensity
3.3. Regional Outlook

4.MARKET DYNAMICS

4.1. Drivers
4.2. Opportunity
4.3. Restraints
4.4. Trends
4.5. PESTEL Analysis
4.6. Demand Side Analysis
4.7. Supply Side Analysis
- 4.7.1. Merger & Acquisition
- 4.7.2. Investment Scenario
- 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

5.1. Regional Pricing Analysis
5.2. Price Influencing Factors

6.GLOBAL 3D CARDIAC MAPPING SYSTEM MARKET REVENUE (USD MN), 2022-2032F

7.MARKET INSIGHTS BY TYPE

7.1. Electroanatomical Mapping
7.2. Basket Catheter Mapping
7.3. Real-time positional management (cardiac pathways) EP system

8.MARKET INSIGHTS BY APPLICATION

8.1. Hospitals & Clinics
8.2. Ambulatory Surgical Centers
8.3. Others

9.MARKET INSIGHTS BY REGION

9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Rest of North America
9.2. Europe
- 9.2.1. Germany
- 9.2.2. U.K.
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Rest of Asia-Pacific
9.4. Rest of World

10.VALUE CHAIN ANALYSIS

10.1. Marginal Analysis
10.2. List of Market Participants

11.COMPETITIVE LANDSCAPE

11.1. Competition Dashboard
11.2. Competitor Market Positioning Analysis
11.3. Porter Five Forces Analysis

12.COMPANY PROFILED

12.1. Abbott
- 12.1.1. Company Overview
- 12.1.2. Key Financials
- 12.1.3. SWOT Analysis
- 12.1.4. Product Portfolio
- 12.1.5. Recent Developments
12.2. Acutus Medical, Inc.
12.3. APN Health, LLC
12.4. BioSig Technologies, Inc.
12.5. Biotronik
12.6. Boston Scientific Corporation
12.7. Catheter Precision Inc.
12.8. Johnson & Johnson Services, Inc.
12.9. Koninklijke Philips N.V.
12.10. Medtronic